Cefaléia Associada aos Ciclos Hormonais da Mulher
DOI:
https://doi.org/10.34024/rnc.2000.v8.8936Palavras-chave:
Migrânea menstrual, fisiopatologia, tratamentoResumo
Os ciclos normais da vida da mulher estão associados a marcadores hormonais: menarca, ovulação, gravidez, amamentação, uso de contraceptivos, menopausa e terapia de reposição hormonal. Esses eventos e intervenções alteram os níveis e ciclos dos hormônios sexuais e podem causar mudança na prevalência ou intensidade das cefaléias. Cefaléias que acompanham a síndrome pré-menstrual parecem ser geradas centralmente, envolvendo o sistema nervoso central, incluindo os sistemas serotoninérgicos moduladores de dor. As medicações específicas para migrânea, como os triptanos, podem ser efetivas para o tratamento agudo da migrânea menstrual. Entretanto, é importante reconhecer as relações entre a migrânea e o ciclo menstrual, porque a cefaléIa pode não responder aos tratamentos antimigranosos usuais.
Referências
Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. JAMA, 267:64-9, 1992. DOI: https://doi.org/10.1001/jama.267.1.64
Massiou H, Bousser MG. Influence of hormones on migrane. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds.). The Headaches. Philadelphia, Lippincott Williams & Wilkins, 2000, p. 261-7.
Epstein MT, Hockaday JM, Hockaday TDR. Migraine and reproductive hormones throughout the menstrual cycle. Lancet, 1:543-8, 1975. DOI: https://doi.org/10.1016/S0140-6736(75)91558-5
Macgregor A. Migraine in women. London, Martin Dunitz, 1999. p. 90. DOI: https://doi.org/10.4324/9780203427187
Singh I, Singh D. Progesterone in the treatment of migraine. Lancet, 1:745, 1947. DOI: https://doi.org/10.1016/S0140-6736(47)91493-1
Greene R, Dalton KD. The premenstrual syndrome. Brit Med J, 1:1007, 1953. DOI: https://doi.org/10.1136/bmj.1.4818.1007
Dalton KD. Progesterone suppositories and pessaries in the treatment of menstrual migraine. Headache, 12: 150-8, 1973. DOI: https://doi.org/10.1111/j.1526-4610.1973.hed1204151.x
Somerville BW. The role of oestradiol withdrawal in the etiology of menstrual migraine. Neurology, 22:355-65, 1972. DOI: https://doi.org/10.1212/WNL.22.4.355
Welch KMA, Darnely D, Simkings RT. The role of estrogen in migraine: a review and a hypothesis. Cephalalgia, 4:227-36, 1984.
DiCarlo C, Bifulco G, Pellicano M, Napolitano V, Nappi C. Hormonal treatment of premenstrual syndrome. Cephalalgia, 17(suppl. 20):17-9, 1997. DOI: https://doi.org/10.1177/0333102497017S2006
Fioroni L, Martignoni E, Facchinetti F. Changes of neuroendocrine axes in patients with menstrual migraine. Cephalalgia, 15:297-300, 1995. DOI: https://doi.org/10.1046/j.1468-2982.1995.1504297.x
Benedetto C, Allais G, Ciochetto D, DeLorenzo C. Pathopysiological aspects of menstrual migraine. Cephalalgia, 17(suppl. 20):2-4, 1997. DOI: https://doi.org/10.1177/0333102497017S2010
Carlson LA, Ekelund LG, Oro L. Clinical and metabolic effects of different doses of prostaglandin E in man. Acta Med Scand, 183:423-30, 1968. DOI: https://doi.org/10.1111/j.0954-6820.1968.tb10502.x
Nattero G, Allais G, DeLorenzo C, Torre E, Ancona M, Benedetto C, Massobrio M. Menstrual migraine: new biochemical and psychological aspects. Headache, 28:103-7, 1988.
Nattero G, Allais G, DeLorenzo C, Benedetto C, Zonca M, Melzi E, Massobrio M. Relevance of prostaglandins in true menstrual migraine. Headache, 29:233-8, 1989. DOI: https://doi.org/10.1111/j.1526-4610.1989.hed22904233.x
Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache, 30:705-9, 1990.
Benedetto C, Massobrio M, Zonca M. Menstrual migraine: a possible pathogenic implication of platelet function. Gynecol Endocrinol, 1:345-53, 1987.
Leira R, Martinez F, Castillo J, Rodriguez JR, Lema M, Noya M. Hormonal profile and changes in platelet aggregation in menstrual migraine. Neurologia, 5:306-9, 1990.
Taylor DL, Mathew RJ, Ho BT, Weinamn ML. Serotonin levels and platelet uptake during prementrual tension. Neuropsychobiology, 12:16-8, 1984. DOI: https://doi.org/10.1159/000118103
Rapkin AJ, Edelmuth E, Chang LC, Reading AE, McGuire MT, Su TP. Whole blood serotonin in premenstrual syndrome. Obstet Gynecol, 70:533-7, 1987.
Silberstein SD, Merriam GR. Estrogens, progestins and headache. Neurology, 41:786-93, 1991. DOI: https://doi.org/10.1212/WNL.41.6.786
D’Andrea G, Hasselmark L, Cananzi AR, Alecci M, Perini F, Zamberlan F, Welch KMA. Metabolism and menstrual cycle rhytmicity of serotonin in primary headaches. Headache, 35:216-21, 1995. DOI: https://doi.org/10.1111/j.1526-4610.1995.hed3504216.x
Allais G, Facco G, Ciochetto D, DeLorenzo C, Piore M, Benedetto C. Patterns of platelet aggregation in menstrual migraine. Cephalalgia, 17(suppl. 20):39-41, 1997. DOI: https://doi.org/10.1177/0333102497017S2012
Fioroni L, D’Andrea G, Alecci M, Cananzi A, Facchinetti F. Platelet serotonin pathway in menstrual migraine. Cephalalgia, 16:427-30, 1996. DOI: https://doi.org/10.1046/j.1468-2982.1996.1606427.x
Facchinetti F, Nappi G, Petraglia F, Volpe A, Genazzani AR. Oestradiol/progesterone inbalance and the premenstrual syndrome. Lancet 1983; ii:1302. DOI: https://doi.org/10.1016/S0140-6736(83)91172-8
Ghose K, turner P. The menstrual cycle and tyramine pressor response test. Br J Clin Pharmacol, 4:500-2, 1977. DOI: https://doi.org/10.1111/j.1365-2125.1977.tb00776.x
Magos AL, Brincat M, Zikha EJ, Studd JWW. Serum dopamineb-hydroxilase activity in mesntraul migraine. J Neurol Neurosurg Psychiatry, 48:328-31, 1985. DOI: https://doi.org/10.1136/jnnp.48.4.328
Jones SB, Bylund DB, Rieser CA, Shekim WO, Byer JA, Carr GW. α-2-adrenergic receptor binding in human platelets: alterations during the menstrual cycle. Clin Pharmacol Ther, 34:90-6, 1983.
Facchinetti F, Martignoni E, Nappi G, Fioroni L, Sances G, Genazzani AR. Premenstrual failure of α-adrenergic stimulation on hypothalamus-pituitary responses in menstrual migraine. Psychosom Med, 51:550-8, 1969. DOI: https://doi.org/10.1097/00006842-198909000-00006
Murialdo G, Fonzi S, Costelli P, Solinas GP, Parodi C, Marabini S. Urinary melatonin excretion though out the ovarian cycle in menstrual related migrane. Cephalalgia, 14:205-9, 1994. DOI: https://doi.org/10.1046/j.1468-2982.1994.014003205.x
Awaki E, Takeshima T, Takahashi K. A neuroendocrinological study in female migraneurs: prolactin and thyroid stimulting hormone responses. Cephalalgia, 9:187-93, 1989.
Consenso da Sociedade Brasileira de Cefaléia. Recomendações para o tratamento da crise migranosa. Arq Neuropsiquiatr, 58(2-A):371-89, 2000. DOI: https://doi.org/10.1590/S0004-282X2000000200029
Pfaffenrath, V. Efficacy and safety of percutaneous estradiol vs placebo in menstrual migrane. Cephalalgia, 13 (suppl. 13):244, 1993. DOI: https://doi.org/10.1177/0333102493013S1212
Steiner M, Steinberg S, Stewart D et al. Fluoxetin in the treatment of premenstrual dysphoria. N Engl J Med, 332:1529-34, 1995. DOI: https://doi.org/10.1056/NEJM199506083322301
Facchinetti F, Bonellie G, Kangasniemi P, Pascual J, Shuaib A. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migrane. Obstet Gynecol, 86:911-6, 1995. DOI: https://doi.org/10.1016/0029-7844(95)00288-3
Murray SC, Muse KN. Effective treatment of severe menstrual migraine headaches with gonadotropin-realising hormone agonist and “add-back” therapy. Fertil Steril, 67(2):390-3, 1997. DOI: https://doi.org/10.1016/S0015-0282(97)81928-0
Newman LC, Lipton RB, Lay CL, Solomon S. A pilot study of oral sumatriptan as intermitent prophylaxis of menstruationrelated migrane. Neurology, 51:307-9, 1998. DOI: https://doi.org/10.1212/WNL.51.1.307
Grunfeld E, Gresty MA. Relationship between motion sickness, migrane and menstruation in crew members of a “round the world” yacht race. Brain Research Bull, 47(5):433-6, 1998. DOI: https://doi.org/10.1016/S0361-9230(98)00099-9
Silberstein SD, Armellino JJ, Hoffman HD, Battikha JP, Hamelsky SW, Stewart WF, Lipton RB. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies. Clin Ther, 21(3):475-91, 1999.
